Efficacy and Safety of Tezepelumab in the Treatment of Adults With Moderate to Very Severe COPD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
Lancet Respir Med 2024 Dec 06;[EPub Ahead of Print], D Singh, CE Brightling, KF Rabe, MK Han, SA Christenson, MB Drummond, A Papi, ID Pavord, NA Molfino, G Almqvist, A Kotalik, Å Hellqvist, M Gołąbek, NS Sindhwani, SS PonnarambilFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.